TECHNOLOGY DRIVEN CHEMISTRY

As a CDMO/CMO, Kaneka develops new technologies for both Research and Manufacturing under collaboration or in direct support of our Customers' needs. These New Technology Developments support programs from early to late clinical stage, as well as commercial supply.

Key Technologies

Effective combination of biotechnology and synthetic technology

Enzyme Technology

Enzyme Technology

Flow Technology

Flow Technology

API Technology

API Technology

Manufacturing

Flexibility responding to volume and technologies

Products

A variety of chiral
compounds list

50 years experience
in small molecule field

Since the early 1970s, Kaneka has been manufacturing numerous specialty pharmaceutical targets using a combination of synthetic and biotechnology, with a specialty in chiral compounds. The 2018 addition of a Kaneka designed continuous flow system for use at commercial scale has expanded our technology offerings to the market, and is an excellent complement to our existing technology platform.

50 years experience in small molecule field

News

Launch of New Website